UBS Group
INDP icon

UBS Group’s Indaptus Therapeutics INDP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-87
Closed -$49 9124
2025
Q1
$49 Sell
87
-2,436
-97% -$1.37K ﹤0.01% 8697
2024
Q4
$2.12K Buy
2,523
+2,001
+383% +$1.69K ﹤0.01% 7858
2024
Q3
$647 Sell
522
-170
-25% -$211 ﹤0.01% 7638
2024
Q2
$1.47K Sell
692
-1,244
-64% -$2.64K ﹤0.01% 7409
2024
Q1
$4.34K Sell
1,936
-1,763
-48% -$3.95K ﹤0.01% 6464
2023
Q4
$6.51K Buy
3,699
+3,562
+2,600% +$6.27K ﹤0.01% 6487
2023
Q3
$377 Sell
137
-503
-79% -$1.38K ﹤0.01% 7391
2023
Q2
$1.22K Buy
+640
New +$1.22K ﹤0.01% 6894
2022
Q2
Sell
-3,294
Closed -$13K 9471
2022
Q1
$13K Sell
3,294
-1,638
-33% -$6.46K ﹤0.01% 7005
2021
Q4
$28K Buy
4,932
+4,800
+3,636% +$27.3K ﹤0.01% 6346
2021
Q3
$1K Buy
+132
New +$1K ﹤0.01% 8036
2021
Q1
Sell
-802
Closed -$3K 8065
2020
Q4
$3K Sell
802
-26,498
-97% -$99.1K ﹤0.01% 6973
2020
Q3
$7K Sell
27,300
-18,606
-41% -$4.77K ﹤0.01% 6235
2020
Q2
$13K Buy
45,906
+10,860
+31% +$3.08K ﹤0.01% 5983
2020
Q1
$7K Buy
35,046
+33,939
+3,066% +$6.78K ﹤0.01% 6223
2019
Q4
$1K Sell
1,107
-503
-31% -$454 ﹤0.01% 6867
2019
Q3
$1K Buy
1,610
+426
+36% +$265 ﹤0.01% 6866
2019
Q2
$5K Sell
1,184
-38,331
-97% -$162K ﹤0.01% 6496
2019
Q1
$290K Sell
39,515
-13,330
-25% -$97.8K ﹤0.01% 3654
2018
Q4
$398K Buy
52,845
+52,795
+105,590% +$398K ﹤0.01% 3654
2018
Q3
$0 Sell
50
-23,690
-100% ﹤0.01% 7087
2018
Q2
$104K Sell
23,740
-8,079
-25% -$35.4K ﹤0.01% 4532
2018
Q1
$201K Buy
31,819
+4,871
+18% +$30.8K ﹤0.01% 3985
2017
Q4
$139K Sell
26,948
-5,364
-17% -$27.7K ﹤0.01% 4244
2017
Q3
$289K Buy
+32,312
New +$289K ﹤0.01% 3791
2017
Q1
Sell
-875
Closed -$5K 6731
2016
Q4
$5K Buy
875
+239
+38% +$1.37K ﹤0.01% 6260
2016
Q3
$4K Sell
636
-1,710
-73% -$10.8K ﹤0.01% 6262
2016
Q2
$11K Sell
2,346
-556
-19% -$2.61K ﹤0.01% 5831
2016
Q1
$12K Sell
2,902
-1,200
-29% -$4.96K ﹤0.01% 5696
2015
Q4
$22K Buy
4,102
+2,806
+217% +$15K ﹤0.01% 5485
2015
Q3
$7K Buy
+1,296
New +$7K ﹤0.01% 6111